ProHance is a macrocyclic, nonionic, gadolinium-based magnetic resonance imaging (MRI) contrast agent designed for use in MRI in adults and children over two years of age to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. ProHance is also indicated for use in MRI in adults to visualize lesions in the head and neck.
June 9, 2008 - Siemens unveiled the ACUSON SC2000 volume imaging ultrasound system, which acquires nonstitched, real ...
The Deficit Reduction Act of 2005 (DRA), which went into effect on January 1, 2007, has left its mark on hospitals and ...
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
The FDA granted tentative approval for Covidien’s Abbreviated New Drug Application (ANDA) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien’s tentatively approved product is a generic of Cardiolite, which is a myocardial perfusion imaging agent used for detecting coronary artery disease.
June 9, 2008 - Curlin Medical was recently awarded a three-year contract to provide its advanced pain management-local ...
The FDA recently approved Covidien’s contrast delivery system with radiofrequency identification (RFID) technology ...
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
The EmpowerMR injector system has multiple features created to cope with the problem of electrical interference in the ...
The future is looking bright for virtual colonoscopy (CTC) after encouraging news came out that the Centers for Medicare ...
June 9, 2008 – Electronic health records maker MediNotes Corp. said it added 199 new software agreements with new and ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
GE received FDA clearance for its new Signa MR750 3.0T scanner that delivers up to 60 percent additional anatomical ...
The ACIST CVi Contrast Delivery System provides one injection system for all cardiac and vascular angiography procedures. The variable-rate ACIST CVi system aims to provide ease of operation for clinicians, while obtaining quality images with less contrast used and delivered to the patient.
June 9, 2008 - Siemens Medical Solutions gained FDA 510(k) market clearance for the SOMATOM Definition AS, what is said ...
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
June 9, 2008 - At the request of its membership, the American College of Physicians (ACP) recently conducted an ...
June 6, 2008 – e-MD’s electronic health record (EMR) solution, Solution Series, is the best EMR solution, according to ...
June 6, 2008 - Misys Healthcare Systems has introduced its new Reseller Partner Program, designed to enable partner ...
June 6, 2008 - InSite One and eHealth Global signed a co-marketing agreement in hopes of offering the medical imaging ...
June 5, 2008 - Merge Healthcare Inc. is reorganizing its business operations and making changes in executive management ...
June 5, 2008 – There was a 14 percent increase in MRI procedures from 2003 to 2007, for an average annual rate of 3 ...
June 5, 2008 – Doctors at the Louisiana Immersive Technologies Enterprises (LITE) complex Lafayette. LA, recently met ...
June 5, 2008 - Images from inside the body can be made with tiny cameras a patient swallows, but until now doctors have ...
June 08, 2008 